Literature DB >> 8666323

Spontaneous bacterial empyema in cirrhotic patients: a prospective study.

X Xiol1, J M Castellví, J Guardiola, E Sesé, J Castellote, A Perelló, X Cervantes, M J Iborra.   

Abstract

Spontaneous bacterial empyema (SBEM) is an infection of a preexisting hydrothorax in cirrhotic patients and has seldom been reported. To determine its incidence and primary characteristics, all cirrhotic patients with pleural effusion underwent thoracentesis at our hospital either on admission or when an infection was suspected. Pleural fluid (PF) study included biochemical analysis, polymorphonuclear (PMN) leukocyte count, and culture by two methods: conventional and modified (inoculation of 10 mL of PF into a blood culture bottle at the bedside). SBEM was defined according to previously reported criteria: PF culture positive or PMN count greater than 500 cells/micro L, and exclusion of parapneumonic effusions. Sixteen of the 120 (13 percent) cirrhotic patients admitted with hydrothorax had 24 episodes of SBEM. In 10 of the 24 episodes (43 percent), SBEM was not associated with spontaneous bacterial peritonitis (SBP). PF culture was positive by the conventional method in 8 episodes (33 percent) and by the modified method (blood culture inoculation) in 18 (75 percent) (P = .004, McNemar). The microorganisms identified in PF were Escherichia coli in 8 episodes, Streptococcus species in 4, Enterococcus species in 3, Klebsiella pneumoniae in 2, and Pseudomonas stutzeri in 1. All episodes were treated with antibiotics without inserting a chest tube in any case. Mortality during treatment was 20 percent. We conclude that SBEM is a common complication of cirrhotic patients with hydrothorax. Almost half of the episodes were not associated with SBP; thus, thoracentesis should be performed in patients with cirrhosis, pleural effusion, and suspected infection. Culture of PF should be performed by inoculating 10 mL into a blood culture bottle at the bedside.

Entities:  

Mesh:

Year:  1996        PMID: 8666323     DOI: 10.1002/hep.510230410

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  32 in total

1.  Treating hepatic hydrothorax.

Authors:  Jakob Borchardt; Alona Smirnov; Lora Metchnik; Stephen Malnick
Journal:  BMJ       Date:  2003-04-05

2.  Bacterial infections other than spontaneous bacterial peritonitis in cirrhosis.

Authors:  Chalermrat Bunchorntavakul; Disaya Chavalitdhamrong
Journal:  World J Hepatol       Date:  2012-05-27

3.  Pleural fluid analysis and radiographic, sonographic, and echocardiographic characteristics of hepatic hydrothorax.

Authors:  Puncho Gurung; Mark Goldblatt; John T Huggins; Peter Doelken; Paul J Nietert; Steven A Sahn
Journal:  Chest       Date:  2011-01-27       Impact factor: 9.410

Review 4.  Hepato-cardiac disorders.

Authors:  Yasser Mahrous Fouad; Reem Yehia
Journal:  World J Hepatol       Date:  2014-01-27

5.  Video-assisted thoracoscopic surgery (VATS) for the treatment of hepatic hydrothorax: report of twelve cases.

Authors:  Shi-Ping Luh; Chi-Yi Chen
Journal:  J Zhejiang Univ Sci B       Date:  2009-07       Impact factor: 3.066

6.  Paradigms in the management of hepatic hydrothorax: past, present, and future.

Authors:  Sachin Kumar; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2012-09-25       Impact factor: 6.047

7.  Indwelling Pleural Catheters in Hepatic Hydrothorax: A Single-Center Series of Outcomes and Complications.

Authors:  Christopher Kniese; Khalil Diab; Marwan Ghabril; Gabriel Bosslet
Journal:  Chest       Date:  2018-07-07       Impact factor: 9.410

8.  Spontaneous bacterial empyema in liver cirrhosis: an underdiagnosed pleural complication.

Authors:  Naglaa A H Allam
Journal:  Saudi J Gastroenterol       Date:  2008-01       Impact factor: 2.485

9.  Cirrhotic ascites review: Pathophysiology, diagnosis and management.

Authors:  Christopher M Moore; David H Van Thiel
Journal:  World J Hepatol       Date:  2013-05-27

10.  Klebsiella pneumoniae septic arthritis in a cirrhotic patient with hepatocellular carcinoma.

Authors:  Chang Hwan Park; Young Eun Joo; Sung Kyu Choi; Jong Sun Rew; Sei Jong Kim
Journal:  J Korean Med Sci       Date:  2004-08       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.